Literature DB >> 10195243

JC virus type 2B is found more frequently in brain tissue of progressive multifocal leukoencephalopathy patients than in urine from controls.

H T Agostini1, C F Ryschkewitsch, E J Singer, R W Baumhefner, G L Stoner.   

Abstract

OBJECTIVES: Previous studies have shown that strains of human polyomavirus JC (JCV) of Asian origin (type 2) are much more highly represented in progressive multifocal leukoencephalopathy (PML) brain than would be expected from their frequency of excretion in urine samples of a comparable control group. The present studies were designed to test whether one subtype of type 2 was preferentially elevated. STUDY DESIGN/
METHODS: The statistical relation between JCV subtypes represented in PML brain tissue from 51 probands and those in urine samples from 115 control individuals was examined.
RESULTS: The proportion of the JCV subtype 2B in PML brain (36%) was highly significantly increased relative to its occurrence in control urine samples (5.9%; P < .001). Type 1 and its subtypes were not different in the PML brain and control urine cohorts. The number of type 4 strains in PML brains was reduced, although the difference did not reach statistical significance (P = .08).
CONCLUSIONS: The results predict that the human immunodeficiency virus (HIV)-positive individuals at highest risk of PML infection are those carrying the JCV genotype known as type 2B. Prospective studies will be required to confirm this finding.

Entities:  

Mesh:

Year:  1998        PMID: 10195243

Source DB:  PubMed          Journal:  J Hum Virol        ISSN: 1090-9508


  12 in total

1.  Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients.

Authors:  P Ferrante; M Mediati; R Caldarelli-Stefano; L Losciale; R Mancuso; A E Cagni; R Maserati
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

Review 2.  Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Authors:  Eleonora Tavazzi; Martyn K White; Kamel Khalili
Journal:  Rev Med Virol       Date:  2011-09-21       Impact factor: 6.989

3.  Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals.

Authors:  Serena Delbue; Emanuela Branchetti; Renzo Boldorini; Luca Vago; Pietro Zerbi; Claudia Veggiani; Sara Tremolada; Pasquale Ferrante
Journal:  J Med Virol       Date:  2008-12       Impact factor: 2.327

Review 4.  Genotypes, archetypes, and tandem repeats in the molecular epidemiology and pathogenesis of JC virus induced disease.

Authors:  Walter J Atwood
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

5.  Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment.

Authors:  Pasquale Ferrante; Serena Delbue; Elisabetta Pagani; Roberta Mancuso; Angela Marzocchetti; Elisa Borghi; Renato Maserati; Arabella Bestetti; Paola Cinque
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

6.  JC virus in the Irish population: significant increase of genotype 2 in immunocompromised individuals.

Authors:  Kirsten Schaffer; Noreen Sheehy; Suzie Coughlan; Colm Bergin; William W Hall
Journal:  J Neurovirol       Date:  2006-02       Impact factor: 2.643

7.  JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy.

Authors:  Serena Delbue; Francesca Elia; Camilla Carloni; Eleonora Tavazzi; Enrico Marchioni; Silvia Carluccio; Lucia Signorini; Stefano Novati; Renato Maserati; Pasquale Ferrante
Journal:  J Cell Physiol       Date:  2012-10       Impact factor: 6.384

8.  Association of neurotropic viruses in HIV-infected individuals who died of secondary complications of tuberculosis, cryptococcosis, or toxoplasmosis in South India.

Authors:  Rajesh Kannangai; Jaiprasath Sachithanandham; Anita Mahadevan; Asha Mary Abraham; Gopalan Sridharan; Anita Desai; Vasanthapuram Ravi; Susarla Krishna Shankar
Journal:  J Clin Microbiol       Date:  2013-01-02       Impact factor: 5.948

9.  Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.

Authors:  Renaud A Du Pasquier; Marcelo J Kuroda; Joern E Schmitz; Yue Zheng; Kristi Martin; Fred W Peyerl; Michelle Lifton; Darci Gorgone; Patrick Autissier; Norman L Letvin; Igor J Koralnik
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis.

Authors:  Angela Marzocchetti; Maurizio Sanguinetti; Simona Di Giambenedetto; Antonella Cingolani; Giovanni Fadda; Roberto Cauda; Andrea De Luca
Journal:  J Neurovirol       Date:  2007-08       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.